BRIEF-Shenzhen Hepalink Pharma's 2016 net profit down, share trade to halt pending announcement

April 27 (Reuters) - Shenzhen Hepalink Pharmaceutical Co Ltd * Says 2016 net profit down 31.5 percent y/y at 396.9 million yuan ($57.59 million) * Says trading in shares to halt from April 28 pending announcement related to asset acquisition Source text in Chinese: http://bit.ly/2ozwmGQ ; http://bit.ly/2ozub6d Further company coverage: ($1 = 6.8920 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)